Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



From the monthly archives: April, 2017

We are pleased to present below all posts archived in 'April, 2017'. If you still can't find what you are looking for, try using the search box.

Funding competition: biomedical catalyst 2017 round 2 late stage

UK businesses can apply for a share of up to £12 million to develop innovative ideas that will help solve healthcare challenges.

Read the rest of entry »

OBN Appoints New Non-Executive Director to Enhance Board Expertise

Abingdon, UK: OBN the membership organisation supporting the UK’s innovative life sciences companies, announces today the appointment of Bill Fleming to its Board of Directors, effective immediately

Read the rest of entry »

Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering

Philadelphia, USA and Oxford, UK:  Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced the closing of its previously announced registered direct offering of its American Depositary Shares (“ADSs”) following its entry into a definitive agreement with Matrix Capital Management Company, LP (“Matrix”) to purchase an aggregate of approximately US$42,000,000 of its ADSs. Adaptimmune sold 7,000,000 ADSs at a price of $6.00 per ADS.

Read the rest of entry »

MGB Biopharma Closes $1 million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)

Glasgow, Scotland:  MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance, announces today that it has raised $1.15 million in a financing round with existing investors.

Read the rest of entry »

Heptares to receive US$12 million milestine payment from AstraZeneca

London, UK: AZD4635 (HTL-1071), a novel adenosine A2A receptor antagonist, reverses adenosine-mediated T-cell suppression and enhances anti-tumour immunity.  New preclinical results presented at AACR Annual Meeting

Read the rest of entry »

Imanova receives £1m award from the MRC to develop early markers of dementia - the MIND-MAPS study

Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers for mitochondrial dysfunction and synaptic loss, Imanova has been awarded an additional £1m of strategic funding from the MRC for clinical evaluation of this combination of tracers in Alzheimer’s disease and Parkinson’s disease - Stage 1 of the MIND-MAPS (Molecular Imaging of Neurodegenerative Disease – Mitochondria, Associated Proteins & Synapses) programme. Kevin Cox, Imanova’s CEO, commented: “We are delighted to have been awarded strategic funding for the MIND-MAPS programme. We would like to thank the MRC and Dementias Platform UK (DPUK) for supporting the proposal and look forward to engaging more widely with the DPUK Imaging Network.” MIND-MAPS is a pre-competitive consortium between Imanova, AbbVie, the MRC, the Hamamatsu Photonics PET centre, drawing on the therapy area expertise of the DPUK members. The aim of the prog ...

Read the rest of entry »

Minister breaks ground and unveils name for £13 million office & laboratory building at The Oxford Science Park

The minister of state for universities, science, research and innovation, Jo Johnson MP, visited The Oxford Science Park (“the Park”) on Tuesday 4 April 2017 to take part in an official ground-breaking ceremony and reveal the name of the £13 million state of the art new office and laboratory building capable of accommodating 500 people.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.